Subscribe To

Price Alert Latest News Economic Calendar News

VNDA / Vanda: A Dual Growth And Value Player

Amid the biotech bear market, many fundamentally sound companies are trading at a fraction of their intrinsic value. Read More

Demo Live Account See Partner Details

Content Topics

VNDA

Posted: Apr 11 2022, 14:43

Author Name: Seeking Alpha

VNDA News

By PRNewsWire
September 6, 2023

Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference

WASHINGTON , Sept. 6, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the

By The Motley Fool
September 5, 2023

Why Shares of Vanda Pharmaceuticals Are Dropping on Tuesday

Vanda is being dropped from the S&P 600 SmallCap 600. The company is suing the federal government over what it says was the release of trade secrets r

By Zacks Investment Research
September 1, 2023

After Plunging -7.98% in 4 Weeks, Here's Why the Trend Might Reverse for Vanda (VNDA)

The heavy selling pressure might have exhausted for Vanda (VNDA) as it is technically in oversold territory now. In addition to this technical measure

By PRNewsWire
April 27, 2023

Vanda Pharmaceuticals to Announce First Quarter 2023 Financial Results on May 3, 2023

Conference Call and Webcast to Follow WASHINGTON , April 27, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it

By Seeking Alpha
February 8, 2023

Vanda Pharmaceuticals Inc. (VNDA) Q4 2022 Earnings Call Transcript

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA ) Q4 2022 Earnings Conference Call February 8, 2023 4:30 AM ET Company Participants Kevin Moran - CFO Mihael P

By PRNewsWire
February 1, 2023

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2022 Financial Results on February 8, 2023

Conference Call and Webcast to Follow WASHINGTON , Feb. 1, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it w

By Seeking Alpha
November 2, 2022

Vanda Pharmaceuticals Inc. (VNDA) Q3 2022 Earnings Call Transcript

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA ) Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Kevin Moran - Senior Vice

By PRNewsWire
September 8, 2022

Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference

WASHINGTON , Sept. 8, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that the company will participate in the

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Subscribe To

Live Trading Account

Open live account in few minutes with just 10$

VNDA / Vanda: A Dual Growth And Value Player

Vanda

Dual

Growth

Value

Player

Vanda

Stock

VNDA

VNDA News

Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference

Why Shares of Vanda Pharmaceuticals Are Dropping on Tuesday

After Plunging -7.98% in 4 Weeks, Here's Why the Trend Might Reverse for Vanda (VNDA)

Vanda Pharmaceuticals to Announce First Quarter 2023 Financial Results on May 3, 2023

Vanda Pharmaceuticals Inc. (VNDA) Q4 2022 Earnings Call Transcript

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2022 Financial Results on February 8, 2023

Vanda Pharmaceuticals Inc. (VNDA) Q3 2022 Earnings Call Transcript

Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference